4
Changes in Ownership
Processa Pharmaceuticals, Inc. Filed Acc 0001567619-23-000317
Director acquired 18,208 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| THOMPSON VIRGIL Director | 2022-12-31 | Option exercise | +18,208 | 100,213 | I: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| THOMPSON VIRGIL Director | 2023-01-01 | Grant or award · Restricted Stock | +30,000 | 30,000 | D: show line 2 in the form |
Loading xslF345X03/doc1.xml…